Welcome to our dedicated page for Tomi Environmental Solutions I news (Ticker: TOMZ), a resource for investors and traders seeking the latest updates and insights on Tomi Environmental Solutions I stock.
Overview
TOMI Environmental Solutions Inc. (NASDAQ: TOMZ) is a globally recognized decontamination and infection prevention company that provides innovative environmental solutions focused on indoor surface disinfection. Utilizing its proprietary Binary Ionization Technology (BIT), the company manufactures, sells, and licenses its SteraMist platform of products, which harness a uniquely engineered, low concentration hydrogen peroxide solution. This state‐of‐the‐art technology, developed in collaboration with defense research agencies, has been instrumental in addressing chemical and biological threats, establishing TOMI as a trusted partner in environments where precision, safety, and efficiency are paramount.
Technology and Innovation
The cornerstone of TOMI’s offerings is its patented BIT technology. This innovative process activates and ionizes a 7.8% hydrogen peroxide solution to generate a fine mist or fog of ionized Hydrogen Peroxide (iHP). The resulting aerosol acts as a non‐corrosive, efficient decontaminant that eliminates microorganisms including bacteria, viruses, and fungi. Developed under a defense grant in partnership with agencies such as DARPA, this technology was engineered in response to critical contamination threats and remains unique in its ability to disinfect a range of sensitive materials, from delicate electronics to high-traffic facilities.
Products and Services
The SteraMist brand distinguishes TOMI’s comprehensive product portfolio, which includes systems designed for surface and environmental decontamination. Key products encompass:
- SteraMist Surface Unit – a solution for targeted area decontamination.
- SteraMist Environment System – designed for whole-room or facility-wide disinfection.
- SteraMist Total Disinfection Cart – enabling mobile deployment in diverse settings.
- Custom Engineered Systems (CES) – tailored to meet specific industrial and institutional decontamination requirements.
In addition to manufacturing and direct sales, the company leverages a licensing model for its proprietary technology, thereby establishing a recurring revenue stream and broadening its market reach. The integration of service and training programs ensures that customers consistently achieve optimal disinfection results while adhering to stringent safety protocols.
Industries Served
TOMI’s decontamination solutions are engineered for a broad spectrum of applications. Its products and systems are widely used in:
- Healthcare Facilities: Hospitals, medical centers, and biosafety laboratories that require rigorous infection control.
- Life Sciences and Research: Pharmaceutical labs and research institutions where contamination control is critical.
- Commercial and Institutional Buildings: Office complexes, schools, and universities that benefit from non-corrosive, high-efficiency disinfection.
- Transportation and Public Venues: Cruise ships, sports facilities, and public transportation centers needing rapid, effective sanitation.
- Government and Defense: Facilities that require robust decontamination solutions to address both routine and emergency threats.
Business Model and Value Proposition
TOMI Environmental Solutions operates on a multi-faceted business model that includes direct sales, licensing of its patented BIT technology, and customized service offerings. This diversified approach allows the company to generate recurring revenues while maintaining high margins through its innovative decontamination solutions. The razor/razor-blade model is evident in how the company leverages its foundational BIT technology to drive ongoing services and integration, setting a strong standard in the field of infection prevention.
Market Position and Competitive Landscape
In a competitive environment where effective decontamination is critical, TOMI differentiates itself through its advanced technological platform and a rich history in research-backed innovation. The company has carved out a unique niche by developing a non-corrosive, efficient cleaning solution that minimizes downtime and protects sensitive materials. This is particularly vital in sectors such as healthcare and life sciences, where operational continuity and precision decontamination are non-negotiable. TOMI’s adherence to rigorous safety standards and its capacity to create tailored solutions further reinforce its standing within the market.
Commitment to Quality, Safety, and Compliance
TOMI demonstrably maintains high levels of expertise and trustworthiness through ongoing training programs, comprehensive application protocols, and adherence to industry-specific regulatory standards. The company is associated with multiple professional organizations dedicated to biosafety and infection control, which underscores its commitment to quality and continuous improvement. This robust framework of operational excellence instills confidence in both the efficacy and safety of its decontamination solutions.
Operational Excellence and Global Reach
With a global footprint, TOMI Environmental Solutions has established partnerships with a diverse set of clients, ranging from academic institutions and commercial enterprises to government agencies and military installations. Its emphasis on scalable, customizable systems enables it to address varied decontamination needs across different geographic regions. The company’s proficiency in rapidly deploying technology in response to emergent threats underscores its operational flexibility and technical expertise, ensuring that indoor environments remain safe and contamination-free.
Integrated Research and Development
The continuous evolution of TOMI’s product line is supported by a strong R&D infrastructure dedicated to advancing decontamination technology. By integrating feedback from practical applications in high-stakes environments, the company refines its solutions to enhance performance, safety, and ease of use. This iterative process not only fosters innovation but also solidifies the company’s reputation as an expert in the field of environmental decontamination and infection control.
Overall, TOMI Environmental Solutions stands as a comprehensive provider of decontamination and infection prevention solutions. Its innovative BIT technology and versatile SteraMist platform address the growing need for swift, effective, and safe decontamination across multiple industries. This enduring commitment to technological excellence, operational reliability, and customer-focused innovation positions TOMI as a significant entity within its competitive landscape, catering to stakeholders who value precision, efficiency, and state-of-the-art safety protocols.
By offering reliable, scalable, and innovative decontamination systems, TOMI not only meets current market demands but also continually refines its solutions to address evolving challenges in the realm of infection prevention and environmental safety.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced approximately $1.3 million in orders for its Custom Engineered Systems (CES), including contracts with a Fortune 500 pharmaceuticals company and a leading research facility. This demand reflects a surge in cleanroom utilization in the pharmaceutical sector, prompting a shift to automation in disinfection processes. Despite longer lead times for CES installations, TOMI anticipates revenue realization from these orders in late 2022 and early 2023, driven by increasing sales opportunities and a bolstered technical and R&D team.
TOMI Environmental Solutions (NASDAQ: TOMZ) announced a collaboration with On Demand Pharmaceuticals to enhance drug manufacturing through advanced decontamination solutions using TOMI's SteraMist systems. This partnership, leveraging technologies from DARPA, aims to ensure safe production environments in On Demand's modular cleanroom. The Binary Ionization Technology platform provides efficient disinfection, promoting health and safety in pharmaceutical manufacturing. Both companies are committed to innovation in their respective fields, addressing critical needs in health and safety.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced that H.C. Wainwright has initiated analyst coverage of its common stock. This move aims to increase market visibility and enhance the understanding of TOMI's disinfection solutions utilizing its Binary Ionization Technology (BIT). The company emphasizes that analysts' reports reflect their perspectives and not necessarily those of TOMI. The 31-page report is accessible through H.C. Wainwright. TOMI's BIT platform is used widely across various sectors, including healthcare and food processing, underscoring its importance in infection prevention.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) has launched the SteraMist Amazon Store, showcasing its SteraPak products utilizing Binary Ionization Technology (BIT). This digital storefront enhances sales channels, making purchasing easier for customers. The SteraPak is designed for various environments, offering efficient disinfection without harmful residues. CEO Dr. Halden Shane emphasized the importance of this initiative in expanding the customer base and protecting against emerging pathogens like the Omicron variant and C. auris fungus.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported Q3 2021 revenues of $2.2 million, a 50% increase from Q2 2021. However, this marked a decline from $4.3 million in Q3 2020. Gross margins fell to 59.6% from 66.0% year-over-year. Operating loss stood at $0.5 million, contrasting with an income of $1.1 million in the same quarter last year. The company's net loss was $0.5 million or $0.03 per share. Recent highlights include expanding their product line with SteraPak and establishing an Amazon store. TOMI remains optimistic for continued growth into Q4 2021 and 2022.
TOMI Environmental Solutions, Inc. (NASDAQ:TOMZ) will release its third-quarter financial results after market close on November 12, 2021. A conference call is scheduled for 4:30 p.m. ET to discuss these results. The company specializes in disinfection and decontamination technologies, particularly through its Binary Ionization Technology (BIT) platform and SteraMist product line. The call will be accessible via phone and a live webcast, with a replay available until November 26, 2021.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced EPA registration for its 0.35% hydrogen peroxide BIT Solution, expanding its market reach in food supply chain disinfection. This marks the third EPA registration for the company, allowing the product's use across pre-harvest to distribution phases for various agricultural products. The registration follows extensive research and testing, enabling the solution to combat harmful plant pathogens effectively. CEO Dr. Halden S. Shane expressed confidence that this product will transform food industry decontamination standards.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced that CEO Dr. Halden Shane will present at the LD Micro Main Event on October 12, 2021, at 6:30 PM ET. The presentation will cover TOMI's innovations in disinfection and decontamination technology, particularly their proprietary Binary Ionization Technology® (BIT™) using ionized Hydrogen Peroxide. This technology targets a wide range of commercial and residential environments. Interested parties can register to view the presentation online.
TOMI Environmental Solutions (NASDAQ: TOMZ) has secured a purchase order from a top-five multinational pharmaceutical company for its SteraMist Environment system and validation service. This initial order is intended for a new facility, with expectations of follow-on orders for multiple locations in the U.S. and Europe. TOMI's ionized Hydrogen Peroxide (iHP) technology is eco-friendly and produces no hazardous byproducts, aligning with the company's sustainability goals. The COO expressed confidence in expanding partnerships with prestigious life science customers, enhancing TOMI's market presence.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) announced the closing of a registered direct offering of 2,869,442 shares of common stock at $1.7425 per share, raising approximately $5.0 million. Investors also received warrants to purchase an additional 1,434,721 shares. The proceeds will be allocated towards sales and marketing expenses, inventory purchases, and general corporate purposes. H.C. Wainwright & Co. acted as the exclusive placement agent for this transaction.